DFS and OS in triple negative (a, b) and triple unfavorable (c, d)

Flow diagram of patients included in the IBIS 3 biological study. CMF

Rosella SILVESTRINI, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Istituto Tumori di Milano

PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer

PDF) Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer

of the patients and tumors, showing means and standard deviation for

Mariagrazia BRANDI, University of Ferrara, Ferrara, UNIFE, Department of Life Sciences and Biotechnologies

DFS and OS in triple negative (a, b) and triple unfavorable (c, d)

Laura MEDRI, Azienda Unità Sanitaria Locale Forlì, Forlì, ASL Forli, Anatomia Patologica

of the patients and tumors, showing means and standard deviation for

DFS and OS in triple negative (a, b) and triple unfavorable (c, d)